|
Delayed
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | -99.33% |
| 06/08 | Morphic Medical Announces Board Appointments, Effective August 6, 2026 | CI |
| 03/08 | Morphic Medical Inc. Provides Update On Reset System Clinical And Commercial Progress | CI |
| Market Cap | 440K 388K 368K 332K 625K 42.23M 633K 4.4M 1.69M 21.59M 1.65M 1.62M 69.22M | P/E 2019 |
-1.12x | P/E 2020 | -0.03x |
|---|---|---|---|---|---|
| Enterprise Value | 3.28M 2.89M 2.74M 2.47M 4.66M 314M 4.72M 32.74M 12.6M 161M 12.31M 12.05M 515M | EV / Sales 2019 |
-
| EV / Sales 2020 | - |
| Free-Float |
-
| Yield 2019 * |
-
| Yield 2020 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mike Gutteridge
CEO | Chief Executive Officer | - | 05/08/2025 |
Jane Wright
DFI | Director of Finance/CFO | 57 | 01/08/2025 |
| Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Ginger Glaser
BRD | Director/Board Member | - | 20/10/2020 |
Alex Escalona
BRD | Director/Board Member | - | - |
John R. Barr
BRD | Director/Board Member | 69 | 01/10/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/1/21 | Free | Chairman | 1,384,483 | 0.4875% | ||
| 28/1/21 | Free | Chief Executive Officer | 11,075,869 | 3.8998% |
| 2019 | 2020 | |
|---|---|---|
| Net sales | - | - |
| Net income | -17.33M -15.26M -14.46M -13.06M -24.61M -1.66B -24.92M -173M -66.58M -850M -65.09M -63.67M -2.72B | -11.14M -9.81M -9.29M -8.39M -15.81M -1.07B -16.01M -111M -42.78M -546M -41.82M -40.9M -1.75B |
| Net Debt | 2.89M 2.54M 2.41M 2.17M 4.1M 277M 4.15M 28.82M 11.09M 142M 10.84M 10.6M 454M | 2.84M 2.5M 2.37M 2.14M 4.03M 272M 4.08M 28.34M 10.91M 139M 10.66M 10.43M 446M |
Employees
-
Sector
-
- Stock Market
- Stocks
- GIDYL Stock
Select your edition
All financial news and data tailored to specific country editions
















